A study published March 17 in JAMA Network Open found that transgender, nonbinary and gender-diverse people who were ...

J&J is discontinuing the Phase 3 test of its drug, aticaprant, in major depressive disorder “due to insufficient efficacy in the target patient population,” the company said after Thursday’s ...

Depression and anxiety affect approximately 40% of adults with chronic pain, according to a massive new systematic review and ...

In a statement released Thursday afternoon, J&J said it will stop developing the drug, called aticaprant, as an add-on ...

The blues and the jitters are very common among people battling chronic pain, a new evidence review says. About 40% of adults ...

University of Iowa Health Care is among only three academic medical centers in the nation, and the first in the Midwest, to ...

For parents of children living with significant health issues, it can be hard to find ways to channel fear into hope. For anyone living with major depression and suicidal ideation, it can be hard to ...

Part of you is concerned — after all, you know depression can be serious — but on the other hand, can’t weight loss be a good thing? And is depression weight loss even a thing in the first place?

The latest health news includes Johnson & Johnson halting testing on a depression drug, USDA eliminating food safety advisory ...

Discover the crucial warning signs of retirement depression and learn effective strategies to maintain mental wellness during ...